BioLineRx
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $11,749 | $4,943 | $5,393 | $6,855 |
Gross Profit | 5,660 | 4,121 | 4,496 | 5,400 |
EBITDA | 3,100 | -3,357 | 3,045 | 1,130 |
EBIT | 1,248 | -4,197 | 2,569 | 233 |
Net Income | -3,187 | -5,822 | 484 | -696 |
Net Change In Cash | 11,749 | 4,943 | 5,393 | 6,855 |
Free Cash Flow | -8,605 | -9,825 | -11,356 | -14,141 |
Cash | 10,436 | 8,836 | 9,623 | 5,990 |
Basic Shares | 79,856 | 79,856 | 79,838 | 72,439 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $28,940 | $4,800 | $0 | $0 |
Gross Profit | 19,677 | 1,108 | -654 | -702 |
EBITDA | 3,918 | -57,086 | -28,503 | -24,074 |
EBIT | -147 | -58,470 | -29,157 | -24,777 |
Net Income | -9,221 | -60,614 | -20,745 | -28,144 |
Net Change In Cash | 28,940 | 4,800 | 0 | 0 |
Free Cash Flow | -43,927 | -22,905 | -26,556 | -23,670 |
Cash | 10,436 | 4,255 | 10,587 | 12,990 |
Basic Shares | 79,873 | 64,224 | 51,597 | 44,195 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$1.43 |
2024-09-30 | -$0.07 |
2024-06-30 | $0.006 |
2024-03-31 | -$0.01 |
